関連する実験動画
Updated: Apr 19, 2026

09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
27.7K
臓の循環腫瘍細胞のRNA配列化は,転移におけるWNTシグナル伝達を意味する
Min Yu1, David T Ting, Shannon L Stott
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA.
Nature
|July 6, 2012
まとめ
研究者らは,Wnt2を臓がんの循環腫瘍細胞 (CTC) の鍵となる遺伝子として特定した. Wnt2は癌細胞の生存と転移を促進し,癌の拡散を防ぐための潜在的な治療目標として示唆しています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 癌の転移に関する研究
背景:
- 循環性腫瘍細胞 (CTC) は稀ですが,遠隔転移の開始には極めて重要です.
- CTCにおける細胞経路の特定は,がんの拡散のメカニズムを明らかにすることができます.
研究 の 目的:
- ネズミの臓がんモデルからCTCで濃縮された候補遺伝子と経路を特定する.
- 臓がんの進行と転移における特定された遺伝子の役割を調査する.
主な方法:
- 内生マウスモデルから効率的なCTCキャプチャのためのマイクロ流体装置を適応しました.
- 捕獲されたCTCで単分子RNA配列を解析した.
- WNT2発現が臓がん細胞の行動と転移に及ぼす機能的影響を in vivoで評価した.
主要な成果:
- CTCsで著しく濃縮された候補遺伝子としてWnt2を特定しました.
- 臓がん細胞におけるWNT2発現は,アノイキスを抑制し,アンカレージ独立成長を促進した.
- WNT2は生体内で転移傾向を促進し,フィブロネクチンのアップレギュレーションと相関していました.
- WNTシグナリングは,症例のサブセットでヒトの臓CTCに強化されました.
結論:
- CTCの分子分析は,がん転移の予防のための潜在的な治療標的を特定することができます.
- WNT2は,臓がんの広がりを抑制する潜在的な治療標的です.
関連する概念動画
Canonical Wnt Signaling Pathway
11.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
11.0K
Metastasis
7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
Non-Canonical Wnt Signaling Pathways
8.6K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K

